Company: MVIS
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001641172-25-000783
Chunk: 35

Company: MICROVISION, INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 1A
Chunk 35
---
 principal in the amount of $30.0 million of convertible
    notes to the Holder, subject to certain limitation. We received proceeds, net of all costs, of $38.1 million. 

    ●
    In
    March 2024, we entered into a $150.0 million ATM equity offering agreement with Deutsche Bank Securities, Inc., Mizuho Securities
    USA LLC and Craig-Hallum Capital Group LLC (collectively, the “Agents”). Under the agreement, we are able, at our discretion,
    to offer and sell shares of our common stock having an aggregate value of up to $150.0 million through or directly to the Agents.
    As of December 2024, we completed sales under such sales agreement of 23.3 million shares for net proceeds of $34.7 million. As of
    December 31, 2024, we have approximately $113.6 million available under this sales agreement.

    ●
    In
    June 2021, we entered into a $140.0 million ATM equity offering agreement with Craig-Hallum. Under the agreement we were able, at
    our discretion, to offer and sell shares of our common stock having an aggregate value of up to $140.0 million through Craig-Hallum.
    As of December 31, 2022, we had issued 8.3 million shares of our common stock for net proceeds of $81.8 million under this ATM agreement.
    During the quarter ended March 31, 2023, we issued 5.0 million shares of our common stock for net proceeds of $12.5 million under
    the agreement. The sales agreement was terminated in June 2023.

    ●
    In
    June 2023, we entered into a $45.0 million ATM equity offering agreement with Craig-Hallum. Under the agreement, we were able, at
    our discretion, to offer and sell shares of our common stock having an aggregate value of up to $45.0 million through Craig-Hallum.
    As of June 30, 2023, we had completed sales under such sales agreement, having sold 10.9 million shares for net proceeds of $43.9
    million. No further shares are available for sales under this agreement.

Our
capital requirements will depend on many factors, including, but not limited to, the rate at which OEMs and other potential customers
introduce products incorporating our